Literature DB >> 23750776

Changes in the characteristics and levels of comorbidity among new patients into methadone maintenance treatment program in British Columbia during its expansion period from 1998-2006.

Behnam Sharif1, Bohdan Nosyk, Huiying Sun, David C Marsh, Aslam Anis.   

Abstract

We described the changing characteristics and comorbidity levels of new patients into Methadone maintenance treatment (MMT) program in British Columbia, Canada, during its expansion period of 1998-2006. Analyses used administrative data. Generalized regression models were applied using Charlson Comorbidity Index (CCI) and Chronic Disease Score (CDS) as outcomes. 12,615 individuals initiated MMT during 1998-2006, while their odds of having moderate CCI (1 ≤ CCI ≤ 4) and mean CDS increased by 60% and 11%, respectively, after adjusting for confounders. MMT entrants were presented with progressively higher levels of comorbidity, independent of other characteristics. Future MMT policies should address higher levels of comorbidity among new patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23750776      PMCID: PMC5108241          DOI: 10.3109/10826084.2013.800119

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  24 in total

1.  Correlates of enrollment in methadone maintenance treatment programs differ by HIV-serostatus.

Authors:  N G Shah; D D Celentano; D Vlahov; V Stambolis; L Johnson; K E Nelson; S A Strathdee
Journal:  AIDS       Date:  2000-09-08       Impact factor: 4.177

Review 2.  Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration.

Authors:  Sandro Galea; David Vlahov
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

3.  Systemic disease among cases of fatal opioid toxicity.

Authors:  Shane Darke; Sharlene Kaye; Johan Duflou
Journal:  Addiction       Date:  2006-09       Impact factor: 6.526

4.  Policy changes and the methadone maintenance treatment system for opioid dependence in Ontario, 1996 to 2001.

Authors:  Carol J Strike; Karen Urbanoski; Benedict Fischer; David C Marsh; Margaret Millson
Journal:  J Addict Dis       Date:  2005

5.  Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004.

Authors:  Xinzhi Zhang; Frederic H Decker; Huabin Luo; Linda S Geiss; William S Pearson; Jinan B Saaddine; Edward W Gregg; Ann Albright
Journal:  J Am Geriatr Soc       Date:  2010-04       Impact factor: 5.562

6.  Changing patient characteristics with increased methadone maintenance availability.

Authors:  Bruna Brands; Joan Blake; David Marsh
Journal:  Drug Alcohol Depend       Date:  2002-03-01       Impact factor: 4.492

7.  Methadone medical maintenance in primary care. An implementation evaluation.

Authors:  Joseph O Merrill; T Ron Jackson; Beryl A Schulman; Andrew J Saxon; Asaad Awan; Sonja Kapitan; Molly Carney; Lyndia C Brumback; Dennis Donovan
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

8.  Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users.

Authors:  Andrea A Howard; Robert S Klein; Ellie E Schoenbaum
Journal:  Clin Infect Dis       Date:  2003-05-08       Impact factor: 9.079

Review 9.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.

Authors:  R P Mattick; C Breen; J Kimber; M Davoli
Journal:  Cochrane Database Syst Rev       Date:  2002

10.  Proportional hazards frailty models for recurrent methadone maintenance treatment.

Authors:  Bohdan Nosyk; Ying C MacNab; Huiying Sun; Benedikt Fischer; David C Marsh; Martin T Schechter; Aslam H Anis
Journal:  Am J Epidemiol       Date:  2009-08-11       Impact factor: 4.897

View more
  4 in total

1.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

2.  'Crisis' and 'everyday' initiators: A qualitative study of coercion and agency in the context of methadone maintenance treatment initiation.

Authors:  Will Damon; Will Small; Solanna Anderson; Lisa Maher; Evan Wood; Thomas Kerr; Ryan McNeil
Journal:  Drug Alcohol Rev       Date:  2016-04-29

Review 3.  Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis.

Authors:  Brittany B Dennis; Monica Bawor; Lehana Thabane; Zahra Sohani; Zainab Samaan
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

4.  Large and non-specific somatic disease burdens among ageing, long-term opioid maintenance treatment patients.

Authors:  David Medved; Thomas Clausen; Anne Bukten; Ronny Bjørnestad; Ashley Elizabeth Muller
Journal:  Subst Abuse Treat Prev Policy       Date:  2020-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.